CompletedInterventionalPhase 4Last updated Sep 10, 2021

Tolerance & Responsiveness Improvement for Metformin (TRIM)

Tolerance & Responsiveness Improvement for Metformin (TRIM): Open-label, Parallel-group Randomized Trial, Phase 4

Overview

ClinicalTrials.gov ID: NCT03670043
Lead Sponsor: West Side Institute for Science and EducationOTHER
Brief Summary: The overall goal is to explore the hypothesis that prebiotic fiber Psyllium will ameliorate diarrhea in African American men (AAM) with Type2 Diabetes Mellitus (T2D).
Study Type: Interventional

Status

Overall Status: Completed
Start Date: Mar 19, 2019Actual
Primary Completion Date: Oct 15, 2020Actual
Completion Date: Aug 15, 2021Actual

Study Record Dates

First Submitted: Sep 11, 2018
First Submitted that Met QC Criteria: Sep 11, 2018
First Posted: Sep 13, 2018Actual
Last Update Submitted that Met QC Criteria: Sep 1, 2021
Last Update Posted: Sep 10, 2021Actual
Last Verified: Sep 2021

NCT03467763Completed

Trial of an Intervention to Improve Metformin Persistence and Adherence

NCT01582282Terminated

Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects

NCT04639492Completed

Postbiotic MBS and Metformin Combination in Patients With T2DM

NCT04547790Completed

A Study to Assess the Effect of Psyllium vs. Wheat Dextrin on Glycemic Control and Inflammatory Markets in Diabetes Mellitus 2

NCT01159600Completed

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

NCT07139405Not yet recruiting

TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy